Defining the Role of Host Factors in Ebola Virus RNA Synthesis
Defining the Role of Host Factors in Ebola Virus RNA Synthesis
批准号:
9312744
负责人:
Douglas J. LaCount
金额:
$74.16万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AddressAffectAffinityAffinity ChromatographyBindingBinding ProteinsBiochemicalBioinformaticsBiological AssayBiophysicsCell CommunicationCellsCellular biologyCessation of lifeClinicalClinical TrialsCommunitiesComplexDataData SetDemocratic Republic of the CongoDengue VirusDependenceDevelopmentDisease OutbreaksDrug effect disorderEbola virusFiloviridaeFilovirusGenetic TranscriptionGenomic LibraryGenotypeGoalsGuineaHealthHepatitis CHumanIndividualIntegration Host FactorsLibrariesManuscriptsMapsMass Spectrum AnalysisMethodsMissionMolecularMusMutationNational SecurityNetwork-basedPathway interactionsPharmaceutical PreparationsPolymerasePreparationPrincipal InvestigatorProteinsProteomicsRNA InterferenceRNA chemical synthesisRNA interference screenRNA replicationReportingResearchRiskRoleSmall Interfering RNASystems BiologyTechniquesTechnologyTestingTwo-Hybrid System TechniquesViralViral ProteinsVirusVirus DiseasesVirus ReplicationWestern AfricaWorkYeastsZaire Ebola viruscellular imagingdata sharingexperienceexperimental studyfollow-upgammaherpesvirusgenome-widegenome-wide analysishigh throughput screeningimprovedinsightkillingsnovelnovel strategiespathogenprogramsprotein protein interactionscreeningstatisticstranscriptome sequencingvaccine candidatevirus host interactionweb site
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Program Director/Principal Investigator (Last, First, Middle):
The overall goal of this Project is to identify cellular proteins that are required for Ebola virus replication. Ebola
viruses pose significant risks to human health and national security. The 2014 outbreak in Western Africa
infected more than 28,000 people and caused more than 11,000 deaths (per WHO statistics). Although
vaccine candidates are showing promise in clinical trials, no clinically approved drugs are available and basic
information about Ebola virus replication is lacking. Like all viruses, Ebola virus depends on cellular proteins
for its replication. This dependence creates a potential “Achilles heel” that may be exploited to develop new
approaches to treat Ebola virus infections. By studying Ebola virus-host cell interactions, we gain insight into
the mechanisms of action of viral proteins and the strategies that the virus uses to interface with its host.
However, relatively few host factors of Ebola virus replication have been reported and no systematic, genome-
wide analyses have been performed. To address this gap, we will apply complementary technologies to
develop high quality maps of Ebola virus-host cell interactions. In Aim 1 we perform a high content, genome-
wide RNAi screen under BSL4 conditions with wildtype Ebola virus to identify novel host factors required for
Ebola virus replication. The capacity to perform such a screen is unique to the research team. Since the host
factors identified in the siRNA screen could act directly or indirectly to affect Ebola virus replication, in Aim 2
we propose to identify cellular proteins that bind to Ebola virus replication proteins. Complementary protein-
protein interaction discovery technologies (yeast two-hybrid assay and co-affinity purification plus mass
spectrometry) are used to develop a more comprehensive Ebola virus-host cell protein interaction network than
could be achieved with any single approach. Since the sequences of Ebola virus strains differ between
outbreaks and the impact of these genetic changes on host cell interactions is not known, we systematically
compare host cell binding partners of a 2014 outbreak strain to those of Ebola Zaire (1976). Host cell factors
from Aims 1 and 2 are integrated with existing large-scale data sets in Aim 3 to develop strain-specific Ebola
virus-host cell protein interaction networks. To create a more complete understanding of regulatory effects of
the virus-host interactions, we will enrich the network in indirect transcriptional interactions using high-
throughput RNA-seq profiling of a subset of host factors selected from Aims 1 and 2. Our research team is well
qualified to accomplish the goals of this Project, having expertise in high-throughput screening of BSL4
viruses, virus-host cell protein interactions, RNA-Seq profiling, and network-based bioinformatic analyses. Host
factors will be tested for their effects on virus infection in Projects 1 and 3, and characterized by biophysical
and structural methods in Core B and Project 2. Together these studies will develop the most comprehensive
analysis of Ebola virus-host cell interactions to date. The data is integral to the mission of this Program and is
expected to stimulate hypothesis-driven experiments in broader Ebola virus research community.
0925-0001/0002 (Rev. 08/12) Page Continuation Format Page
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Perturbing virus replication with interfering peptides
-
批准号:10354399
-
项目类别:
-
资助金额:$25.27万
-
财政年份:2022
-
负责人:Douglas J. LaCount
-
依托单位:
Perturbing virus replication with interfering peptides
-
批准号:10613481
-
项目类别:
-
资助金额:$19.87万
-
财政年份:2022
-
负责人:Douglas J. LaCount
-
依托单位:
A temporal view of the Plasmodium-red blood cell interactome
-
批准号:8282783
-
项目类别:
-
资助金额:$28.39万
-
财政年份:2010
-
负责人:Douglas J. LaCount
-
依托单位:
A temporal view of the Plasmodium-red blood cell interactome
-
批准号:8477209
-
项目类别:
-
资助金额:$27.33万
-
财政年份:2010
-
负责人:Douglas J. LaCount
-
依托单位:
A temporal view of the Plasmodium-red blood cell interactome
-
批准号:8090281
-
项目类别:
-
资助金额:$28.05万
-
财政年份:2010
-
负责人:Douglas J. LaCount
-
依托单位:
A temporal view of the Plasmodium-red blood cell interactome
-
批准号:7864488
-
项目类别:
-
资助金额:$28.62万
-
财政年份:2010
-
负责人:Douglas J. LaCount
-
依托单位:
CHARACTERIZATION OF TRYPANOSOMA BRUCEI GP63 PROTEIN
-
批准号:6446633
-
项目类别:
-
资助金额:$2.26万
-
财政年份:2001
-
负责人:Douglas J. LaCount
-
依托单位:
CHARACTERIZATION OF TRYPANOSOMA BRUCEI GP63 PROTEIN
-
批准号:6136273
-
项目类别:
-
资助金额:$3.24万
-
财政年份:2000
-
负责人:Douglas J. LaCount
-
依托单位:
海外基金